financetom
Business
financetom
/
Business
/
Rocket Lab Eyeing Semiconductors Expansion - Inks Initial Pact Worth $23.9M For CHIPS Act Funding
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Rocket Lab Eyeing Semiconductors Expansion - Inks Initial Pact Worth $23.9M For CHIPS Act Funding
Jun 11, 2024 7:03 AM

On Tuesday, Rocket Lab USA, Inc. ( RKLB ) inked a non-binding preliminary memorandum of terms with the Department of Commerce.

Under the deal, Rocket Lab will receive up to $23.9 million in direct funding under the CHIPS and Science Act.

This CHIPS investment would create more than 100 direct manufacturing jobs.

“Semiconductors are central to modern life, to our economy, and to America’s future. We are proud to be strengthening that future with the support of the CHIPS Office by expanding our production facilities to meet growing demand for the semiconductors that power the nation’s most critical science, defense and commercial space missions,” said Rocket Lab founder and CEO Sir Peter Beck. 

Rocket Lab has indicated that it plans to claim the Department of the Treasury’s Investment Tax Credit, which is expected to be up to 25% of qualified capital expenditures.

The investment would enable Rocket Lab to increase its production of compound semiconductors for spacecraft and satellites as part of an expansion and modernization of the company’s facility in Albuquerque, New Mexico.

Rocket Lab also sees a rise in its resilient supply of space-grade solar cells following the development.

The modernization and expansion project would also increase Rocket Lab’s compound semiconductor production by 50% within the next three years, helping to domestically meet the growing national security and consumer demand for these solar cells.

Price Action: RKLB shares are trading lower by 0.56% to $4.534 at last check Tuesday.

Read Next: Tesla Rival Rivian Rolls Out Next-Gen R1S And R1T: Enhanced Performance, Design, And Tech Start At $69,900

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Warner Bros Discovery names key executives under US Networks business head Channing Dungey
Warner Bros Discovery names key executives under US Networks business head Channing Dungey
Dec 18, 2024
Dec 18 (Reuters) - Warner Bros Discovery ( WBD ) on Wednesday named key members of the executive team for its U.S. Networks business, which will be headed by Channing Dungey, chairman and CEO of Warner Bros Television Group. Dungey, who previously held the role of president of ABC Entertainment as well as vice president of original series at Netflix...
Woodside Energy partners with Chevron to swap stakes in various energy projects
Woodside Energy partners with Chevron to swap stakes in various energy projects
Dec 18, 2024
(Reuters) - Australia's Woodside Energy ( WDS ) said on Thursday it had entered into a deal with Chevron ( CVX ) to exchange stakes in a number of energy projects, with the U.S. oil and gas giant making a cash payment of up to $400 million to Woodside. Under the terms of the deal, Woodside will acquire Chevron's (...
Liquidity Services Insider Sold Shares Worth $1,047,925, According to a Recent SEC Filing
Liquidity Services Insider Sold Shares Worth $1,047,925, According to a Recent SEC Filing
Dec 18, 2024
06:03 PM EST, 12/18/2024 (MT Newswires) -- Steven Weiskircher, Senior Vice President & Chief Technology Officer, on December 16, 2024, sold 33,773 shares in Liquidity Services ( LQDT ) for $1,047,925. Following the Form 4 filing with the SEC, Weiskircher has control over a total of 56,942 shares of the company, with 56,942 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1235468/000095017024138016/xslF345X05/ownership.xml ...
Ani Pharmaceuticals Insider Sold Shares Worth $418,425, According to a Recent SEC Filing
Ani Pharmaceuticals Insider Sold Shares Worth $418,425, According to a Recent SEC Filing
Dec 18, 2024
06:02 PM EST, 12/18/2024 (MT Newswires) -- Stephen P. Carey, Senior Vice President & CFO, on December 17, 2024, sold 7,500 shares in Ani Pharmaceuticals ( ANIP ) for $418,425. Following the Form 4 filing with the SEC, Carey has control over a total of 154,468 shares of the company, with 154,468 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1023024/000167423624000015/xslF345X05/wk-form4_1734562739.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved